Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,727 | -3,861 | -15,508 | -10,477 | -6,864 |
| Depreciation Amortization | 325 | 162 | 649 | 486 | 324 |
| Other Working Capital | -1,474 | -942 | 1,574 | 122 | -8 |
| Other Operating Activity | 516 | 320 | 471 | 349 | 266 |
| Operating Cash Flow | $-8,360 | $-4,321 | $-12,814 | $-9,520 | $-6,282 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 75 | 21 | -30 |
| Investing Cash Flow | $N/A | $N/A | $75 | $21 | $-30 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 392 | 392 | 392 |
| Debt Repayment | N/A | N/A | -392 | -392 | -259 |
| Common Stock Repurchased | N/A | N/A | -3,726 | -3,726 | N/A |
| Financing Cash Flow | $0 | $N/A | $-3,726 | $-3,726 | $133 |
| Exchange Rate Effect | -4 | -1 | -4 | -7 | -3 |
| Beginning Cash Position | 16,331 | 16,331 | 33,088 | 33,088 | 33,088 |
| End Cash Position | 7,968 | 12,009 | 16,331 | 19,585 | 26,648 |
| Net Cash Flow | $-8,364 | $-4,322 | $-16,757 | $-13,503 | $-6,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,360 | -4,321 | -12,814 | -9,520 | -6,282 |
| Capital Expenditure | N/A | N/A | -34 | -34 | -57 |
| Free Cash Flow | -8,360 | -4,321 | -12,848 | -9,554 | -6,339 |